Abstract
Post-transplant lymphoproliferative disorder (PTLD) is a significant complication after pediatric heart transplantation (HT), occurring in 5%-15% of patients within 3years. Data >3years from HT are limited. We sought to describe the prevalence, risk factors, and outcomes of PTLD occurring late (>3years) after pediatric HT in the Pediatric Heart Transplant Study from 1993 to 2010. Among 3844 primary HT patients, 110 (3%) developed late, nonrecurrent PTLD. The hazard rate for late PTLD was constant at 0.01 events/year out to 20years after HT. Risk factors for late PTLD were younger age at HT (HR 1.06, P=0.003) and Epstein-Barr virus (EBV) naivety (HR 1.65, P=0.02). Survival after late PTLD was 86% and 68% at 1 and 5years, with nonwhite race (HR 2.27, P=0.03) and earlier year of HT (HR 1.03, P=0.04) independently associated with mortality. Acute rejection and infection were both common after late PTLD, occurring in 26% and 34% of patients. The constant late hazard and contribution of EBV to late PTLD suggest that vigilance for development of PTLD, including for EBV conversion, should persist indefinitely after pediatric HT. The reasons for elevated risk of death for nonwhites after late PTLD are unclear and warrant further investigation.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call